HopeStage
Back to all studies
CompletedNCT00190775

Atomoxetine compared with placebo for adult ADHD over 38 weeks

About this titleRead the official source — NCT00190775

Researchers compared Atomoxetine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.

Medication studyAges 18+United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Atomoxetine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.

Who was this study for?

This study was for people with ADHD. Listed age limits: from 18 years. Other eligibility criteria applied.

Listed locations
Irvine and 20 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2004
Recruitment status
Completed
Enrollment listed in the registry
502
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00190775
Official title
Show the full official title

A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder: With a Secondary Examination of Impact of Treatment on Family Functioning

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Irvine, United States · Gainesville, United States · Tampa, United States

18 more locations
  • Atlanta, United States
  • Libertyville, United States
  • Indianapolis, United States
  • Bardstown, United States
  • Baltimore, United States
  • Rochester Hills, United States
  • Troy, United States
  • Mount Kisco, United States
  • Chapel Hill, United States
  • Cleveland, United States
  • Toledo, United States
  • Media, United States
  • Houston, United States
  • Salt Lake City, United States
  • Herndon, United States
  • Middleton, United States
  • West Allis, United States
  • Santurce, Puerto Rico

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Atomoxetine Hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including Atomoxetine Hydrochloride and Placebo.

Who was this study for?

This study was for people with ADHD. Listed age limits: from 18 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies